Get the tools used by (smart)2 investors.
SP500 0.3%DOW 0.1%FTSE 100 -0.4%NIKKEI -0.7%OIL 0.2%GOLD 1.4%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Buyback Yield for Novartis AG

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

0QLR: Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

96.11 CHF
Price
– CHF
Fair Value
–
Upside
83.61 - 115.98
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Novartis AG's Buyback Yield:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20241.0%3.0%5.0%7.0%
Performance Summary
  • Novartis's latest twelve months buyback yield is 3.9%
  • Novartis's buyback yield for fiscal years ending December 2020 to 2024 averaged 3.2%.
  • Novartis's operated at median buyback yield of 3.9% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Novartis's buyback yield peaked in December 2022 at 5.4%.
  • Novartis's buyback yield hit its 5-year low in December 2020 of 1.0%.
  • Novartis's buyback yield decreased in 2020 (1.0%, -60.7%), 2023 (4.1%, -23.9%), and 2024 (3.9%, -5.7%) and increased in 2021 (1.5%, +56.6%) and 2022 (5.4%, +255.6%).

Benchmarks

Metric Usage: Buyback Yield

Hide this widget
buyback_yield
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Buyback Yield in the valuation category include:

  • Price / NCAV - Compares the current stock price to the Net Current Asset Value (NCAV) where NCAV equals the company's Current Assets minus its Total Liabilities.
  • P/E Ratio (NTM) - The multiple of forecast earnings for the next twelve months that stock investors are willing to pay for one share of the firm.
  • Daily Close (Trading Days Only) - The trading day's adjusted closing price. Only returns data for trading days.
  • P/E Ratio - Indicates the multiple of earnings that stock investors are willing to pay for one share of the firm.
View Full List

Search for metric or datapoint

Buyback Yield

A ratio that measures the difference between the amount of share repurchases and the amount of share issuances over the trailing twelve months divided...

Definition of Buyback Yield

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-518.3%-318.3%10.6%0400800

The chart above depicts the distribution of buyback yield for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,357 had meaningful values. The average buyback yield of companies in the sector is -22.3% with a standard deviation of 57.6%.

Novartis AG's Buyback Yield of 3.9% ranks in the 97.3% percentile for the sector. The following table provides additional summary stats:

Buyback Yield In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,455
Included Constituents2,357
Min-518.2%
Max6.4%
Median-0.3%
Mean-22.3%
Standard Deviation57.6%

You can find companies with similar buyback yield using this stock screener.

All rights reserved. Terms Of Use